Xvivo Perfusion AB Working Capital to Net Assets Ratio
Xvivo Perfusion AB working capital to net assets ratio. Xvivo Perfusion AB (XVIVO) has a Working Capital to Net Assets ratio of 24.5% as of June 2026. Working capital of Skr540.02 Million (current assets of Skr728.86 Million minus current liabilities of Skr188.83 Million) is measured against net assets of Skr2.20 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Xvivo Perfusion AB (2012–2025)
Working capital to net assets ratio of Xvivo Perfusion AB from 2012 to 2025. This chart shows how Xvivo Perfusion AB's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 24.5%, reflecting working capital of Skr540.02 Million against net assets of Skr2.20 Billion SEK. Explore XVIVO long-term investment intensity to see how much of total assets are deployed in long-term investments.
Xvivo Perfusion AB Working Capital to Net Assets Ratio by Year (2012–2025)
Xvivo Perfusion AB working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Xvivo Perfusion AB from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see XVIVO current and non-current assets.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 26.9% | Skr568.83 Million | Skr2.11 Billion | Skr688.21 Million | Skr119.38 Million | ▼ -2.6 pp |
| 2024 | 29.5% | Skr635.57 Million | Skr2.16 Billion | Skr813.08 Million | Skr177.51 Million | ▼ -6.1 pp |
| 2023 | 35.6% | Skr691.92 Million | Skr1.95 Billion | Skr826.40 Million | Skr134.49 Million | ▲ +12.3 pp |
| 2022 | 23.3% | Skr332.61 Million | Skr1.43 Billion | Skr467.51 Million | Skr134.90 Million | ▼ -11.2 pp |
| 2021 | 34.5% | Skr443.01 Million | Skr1.29 Billion | Skr547.53 Million | Skr104.52 Million | ▼ -4.3 pp |
| 2020 | 38.8% | Skr390.98 Million | Skr1.01 Billion | Skr463.23 Million | Skr72.25 Million | ▲ +2.9 pp |
| 2019 | 35.9% | Skr207.29 Million | Skr577.52 Million | Skr259.88 Million | Skr52.60 Million | ▼ -7.6 pp |
| 2018 | 43.5% | Skr235.11 Million | Skr540.48 Million | Skr277.68 Million | Skr42.57 Million | ▼ -2.8 pp |
| 2017 | 46.3% | Skr233.73 Million | Skr504.33 Million | Skr264.62 Million | Skr30.90 Million | ▲ +24.8 pp |
| 2016 | 21.6% | Skr68.27 Million | Skr316.41 Million | Skr98.11 Million | Skr29.84 Million | ▼ -21.7 pp |
| 2015 | 43.3% | Skr80.05 Million | Skr184.87 Million | Skr95.64 Million | Skr15.58 Million | ▲ +1.1 pp |
| 2014 | 42.2% | Skr74.38 Million | Skr176.18 Million | Skr93.14 Million | Skr18.76 Million | ▲ +34.6 pp |
| 2013 | 7.6% | Skr7.36 Million | Skr96.64 Million | Skr33.02 Million | Skr25.66 Million | ▼ -2.0 pp |
| 2012 | 9.7% | Skr8.57 Million | Skr88.77 Million | Skr32.29 Million | Skr23.72 Million | — |